Cheng, Z., Wang, S., Li, F., Jin, C., Mo, C., Zheng, J., . . . Gu, D. (2024). The potential adverse effects of hypodermic glucagon‐like peptide ‐1 receptor agonist on patients with type 2 diabetes: A population‐based study. Wiley. https://doi.org/10.1111/1753-0407.70013
Style de citation Chicago (17e éd.)Cheng, Zhiyuan, et al. The Potential Adverse Effects of Hypodermic Glucagon‐like Peptide ‐1 Receptor Agonist on Patients with Type 2 Diabetes: A Population‐based Study. Wiley, 2024. https://doi.org/10.1111/1753-0407.70013.
Style de citation MLA (9e éd.)Cheng, Zhiyuan, et al. The Potential Adverse Effects of Hypodermic Glucagon‐like Peptide ‐1 Receptor Agonist on Patients with Type 2 Diabetes: A Population‐based Study. Wiley, 2024. https://doi.org/10.1111/1753-0407.70013.
Attention : ces citations peuvent ne pas être correctes à 100%.